))
Episode 25: Weighing the Risks and Benefits of GLP-1 Medications
Manage episode 451155256 series 3593068
Conteúdo fornecido por Loni and Christine. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Loni and Christine ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
In this episode we dive into the world of GLP-1 receptor agonists - the class of medications (e.g., Ozempic and Wegovy) making headlines for their role in weight management and diabetes care. We explore the science behind GLP-1 medications, their impact on metabolic health, and their growing popularity beyond diabetes treatment. However, it's not all smooth sailing; side effects, accessibility, and long-term outcomes are part of the conversation, too. Whether you're a healthcare professional, a curious patient, or interested in the latest medical advancements, this balanced discussion will help you better understand this groundbreaking class of medications.
25 episódios
Compartilhar
